
|Articles|September 1, 2016
- Pharmaceutical Executive-09-01-2016
- Volume 36
- Issue 9
Pharmaceutical Executive, September 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Pharm Exec's Emerging Pharma Leaders 2016almost 10 years ago
Emerging Leaders 2016: Lessons from the Front Benchalmost 10 years ago
Patient-Centered Strategies for Clinical Trials & Treatmentalmost 10 years ago
Rise of the Vox Populialmost 10 years ago
Opioid Epidemic Prompts More Finger Pointing at Pharmaalmost 10 years ago
Country Report: France, Part IIAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
The New Healthy Aging Imperative and What It Means for Pharma
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5




